Subsequently, ST3GAL4 was found to not only have a high positive coefficient in the risk model, but also to be predominantly expressed in malignant cells (osteoblastic and chondroblastic osteosarcoma cells) compared to other core MRGs (Fig. 8C, Additional file 1: Figure S19 A, C). Here, ST3GAL4 is linked to osteosarcoma.